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Hip complaints differ across age and sex: a
population-based reference data for the
Hip disability and Osteoarthritis Outcome
Score (HOOS)
A Sundén1* , K Lidengren1, E M Roos2, L S Lohmander3 and E Ekvall Hansson1,4
Abstract
Background: The Hip disability and Osteoarthritis Outcome Score (HOOS) is a self-administered hip-specific
questionnaire intended to evaluate symptoms and functional limitations, and it is commonly used to evaluate
interventions in individuals with hip dysfunction or hip osteoarthritis. The HOOS consists of 43 questions in five
subscales: Pain, Symptoms, Function in daily living, Function in sport and recreation and Hip-Related Quality of Life.
This study aimed to establish population-based reference values for the HOOS and to describe the variation of hip-
related symptoms in an adult population.
Methods: The HOOS questionnaire was mailed to 840 individuals aged 18–84 years randomly retrieved from a
national population record for the Skåne region of Southern Sweden.
Results: The overall response rate was 67%. Older women and men consistently reported more hip-related
complaints than those younger. There were significant differences between the oldest and the youngest age
groups in all five subscales in women and men.
Conclusions: Hip-related pain, symptoms, activity of daily life and quality of life varied with age and sex in this
population-based cohort. Our findings show the importance of using age- and sex-matched reference values for
evaluation of outcomes after interventions due to hip-related problems.
Keywords: Osteoarthritis, Hip, HOOS, Reference values
Background
Multi-item disease-specific self-reported outcome mea-
sures have been recommended to assess the effect of inter-
ventions on hip injury and hip osteoarthritis (OA) [1]. The
Hip disability and Osteoarthritis Outcome Score (HOOS)
was established as an extension of The Western Ontario
and McMaster Universities Arthritis Index (WOMAC) by
adding new questions based on over one hundred inter-
views with individuals with hip disability [2–4]. The
HOOS was constructed to better fit, as compared to the
WOMAC, patients’ expectations of more demanding
physical function – for example for younger individuals
and individuals in an early stage of the disease [5]. The
HOOS has been recommended specifically for the evalu-
ation of patients with hip OA undergoing non-surgical or
surgical interventions such as total hip replacement (THR)
[2, 6, 7]. When assessing individuals with hip OA the psy-
chometric properties of the HOOS have shown adequate
test-retest reliability, floor and ceiling effects, and con-
struct validity. The HOOS has also been validated for
short- and long-term follow-up studies of patients with
primary OA assigned for THR [2, 5, 8]. Thus, the HOOS
has psychometric properties that enable researchers and
clinicians to use it with confidence [5, 9–11].
To facilitate the interpretation of responses to interven-
tions and in clinical decision-making, a comparison with
appropriate reference values is essential [12]. However,
there is a lack of reference data for many clinical measures
from the general population, in particular with regard to
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the relationship between demographic factors and
self-reported hip status [12].
Our study aimed to establish reference values for the
HOOS, and to describe the age- and sex-related vari-
ation of hip-related pain, other symptoms, functional
difficulties during daily life as well as sport and recre-
ation, and hip related quality of life.
Methods
A population-based sample was randomly chosen from a
national population record for the Skåne region (Scania)
of Southern Sweden. Everyone in Sweden is registered in
the National Population Records, which is updated every
six weeks. About 1/9 of the Swedish population is in
Skåne – at the time of this study approximately 770,000
individuals aged over 18. Skåne includes both urban and
rural communities. A simple sampling method was used.
From the national population record we requested a ran-
dom sample of 60 men and 60 women from each of seven
age groups (18–24, 25–34, 35–44, 45–54, 55–64, 65–74
and 75–84), for a total of 840 individuals. These age groups
were then collapsed into four age groups (18–34, 35–54,
55–74, and 75–84). This selection of age groups followed
the same procedure as an earlier study on reference values
for the Knee injury and Osteoarthritis Outcome Score
(KOOS) [13]. The number chosen (60 men+ 60 women
/10-year stratum) was based on experience from clinical
studies using the KOOS, where a clinically significant differ-
ence of 10 points has been observed in different populations
after interventions [14–16]. No other demographic charac-
teristics besides age and sex were obtained. The HOOS
questionnaire was mailed together with a cover letter
explaining the purpose of the study, and a prepaid return
envelope. The non-responders were reminded twice with
the same cover letter as the first one together with a new
HOOS questionnaire and a new prepaid return envelope.
Questionnaire
The HOOS is a self-administered disease-specific ques-
tionnaire intended to evaluate symptoms and functional
limitations related to hip osteoarthritis. The questionnaire
is free of charge and can be downloaded from the KOOS
website [17]. The HOOS is available in more than 20 lan-
guages; in this study the Swedish version was used. In this
study, the Swedish version was used [17]. The HOOS is
an adaptation of the KOOS [17–20]. The version used in
this study was the HOOS LK1.0 which contains 43 items
in five subscales: Pain (Pain) (10 items), Symptoms (Symp-
toms) (4 items), Function in daily living (ADL) (21 items),
Function in sport and recreation (Sport/Rec) (3 items) and
Hip-Related Quality of Life (QOL) (5 items). A Likert
scale of five response options is used for each item [17].
The HOOS LK1.0 has been revised, and the most recent
form the HOOS LK2.0 consists of 40 items assessing the
five separate patient-relevant subscales [17]. The HOOS
LK2.0 was not available at the time the data of the present
study was collected.
The HOOS scoring
Standardized answer options were given (5 Likert boxes)
and each item assigned a score from 0 to 4. The scores
from all items within a subscale were then summed. A
separate score was calculated for each of the five sub-
scales and then transformed to a 0 to 100 scale where
100 represented the best result. Traditionally in orthope-
dics, a score of 100 indicates no problems and 0 indi-
cates extreme problems. The normalized score is
transformed to meet this standard [17, 19]. In the
present study, if the number of missing items was more
than 50% in a subscale, the response was considered in-
valid and no subscale score was calculated in accordance
with the HOOS 2013 scoring manual [17].
Statistical analysis
The statistical analyses were performed with SPSS 21.0 for
Windows (SPSS Inc., Chicago, Il, USA). To increase power,
compensate for non-responders, and minimize the number
of comparisons made, the original seven age groups were
collapsed into four age groups when testing for differences
due to age and sex. Reference values for the KOOS were
similarly reported [13]. Analysis of variance, ANOVA, was
used to examine differences between groups. A post hoc test
with Bonferroni correction was used to protect from Type 1
Error due to multiple comparisons. Some of the data were
not normally distributed, but the sample size in each group
was large enough (n ≥ 30) to apply the central limit theorem,
which gives normally distributed sample means [21].
Results
Eight hundred and forty questionnaires were sent out, of
which 45 were returned undelivered because the intended
recipient was deceased or had moved to an unknown ad-
dress (Fig. 1). Of the remaining 795 questionnaires, 537
were returned (response rate 67%). In 34 cases, more than
50% of items were missing for all subscales and no scores
could be calculated. Scores for at least one subscale could
thus be calculated in 503 subjects (63%; 242 men and 261
women) (Fig. 1). The highest response rate, 73%, was
found in the age groups 55–74 and 75–84.
Age-related differences were studied separately in men
and women in the four age-collapsed groups (Fig. 2). For
both men and women, hip function decreased with increas-
ing age.
Age-related differences in women
The oldest age group (75–84 years) reported statistically
significantly more disability than the youngest group
(18–34 years) in all five subscales: Pain (72 vs. 91, p <
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0.001), Symptoms (68 vs. 88, p < 0.001), ADL (69 vs. 93,
p < 0.001), Sport/Rec (56 vs. 91, p < 0.001) and QOL (61
vs. 89, p < 0.001).
Significant differences were also found in the subscales
ADL (69 vs. 81, p = 0.043), Sport/Rec (56 vs. 75, p = 0.017)
and QOL (61 vs. 77, p = 0.028) between women in the two
oldest age groups (75–84 years and 55–74 years) with
more complaints in the oldest age group.
Significant differences were found between the oldest
age group (75–84 years) and the age group 35–54 years
in Pain (72 vs. 87, p = 0.007), Symptoms (68 vs. 86, p =
0.001), ADL (69 vs. 88, p < 0.001), Sport/Rec (56 vs. 83,
p < 0.001) and QOL (62 vs. 85, p < 0.001) with more
complaints in the oldest age group.
Between the age group 55–74 years and the youngest
age group (18–34 years) significant differences were
found in Symptoms (78 vs. 88, p = 0.026), ADL (82 vs.
93, p = 0.012), Sport/Rec (75 vs. 91, p = 0.011) and QOL
(77 vs. 89, p = 0.031) with more complaints in the age
group 55–74 years.
No significant differences were found between the age
group 35–54 years and the youngest age group (18–34 years).
(Table 1 and Fig. 2).
Age-related differences in men
Significant differences were found between the oldest
age group (75–84 years) and the youngest age group
(18–34 years) with more hip problems in the oldest age
group in four subscales: Pain (83 vs. 96, p = 0.03), ADL
(80 vs. 98, p = 0.001), Sport/Rec (69 vs. 93, p < 0.001)
and QOL (81 vs. 93, p = 0.036).
Significant differences were also found between the
age groups 75–84 years and the second youngest age
group (35–54 years) in Sport/Rec (69 vs. 86, p = 0.016),
with more complaints in the oldest age group.
Between the second oldest age group (55–74 years)
and youngest age group (18–34 years) significant differ-
ences were found in Pain (82 vs. 96, p = 0.002), ADL (83
vs. 98, p < 0.001), Sport/Rec (75 vs. 93, p = 0.001) and
QOL (79 vs. 93, p = 0.001) with more hip problems in
the age group 55–74 years.
No statistically significant differences were found in any of
the five subscales between the age group 75–84 and the age
group 55–74 years, age groups 55–74 years and 35–54 years,
or between the two youngest age groups (35–54 years and
18–34 years). (Table 1 and Fig. 2).
Sex-related differences
In the oldest age group, statistically significant differ-
ences between the sexes were found for.
Symptoms (68 vs. 80, p= 0.019) and QOL (61 vs. 81, p=
0.001) where women had more hip problems than men. In
the youngest age group, women had statistically significantly
more hip problems than men in Pain (91 vs. 96, p= 0.003),
ADL (93 vs. 98, p= 0.002) and in QOL (89 vs. 93, p= 0.004).
Fig. 1 Flow chart detailing the study procedure and formation of the patient cohort.
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No significant differences were found between the
sexes in the age groups 55–74 years and 35–54 years.
(Table 1 and Fig. 2).
Discussion
The main aim of this study was to establish reference
data for the HOOS, a patient-reported outcome instru-
ment for individuals with hip OA. To our best know-
ledge, this study is the first to report population-based
reference data for the HOOS.
The difference in reported hip complaints between men
and women was most pronounced in the oldest age group
(75–84 years), with women reporting markedly more com-
plaints than men, especially in QOL, where the difference
was 20 points (81.5 vs. 61.5 points). In Pain, Symptoms,
ADL and Sports/Rec the difference was 11.5–13.3 points
also indicating more complaints in women. In the youngest
age group, women also reported more hip complaints than
men in Pain, Symptoms and ADL.
These results differ from those in the KOOS study (a
similar study population randomly chosen from the same
national population in Skåne), where men aged 75–84 re-
ported more complaints than both younger men and
age-matched women for all subscales but Sport/Rec and
women aged 75–84 reported fewer complaints than those
aged 55–74 [13]. In agreement with the present study the
prevalence of joint complaints was reported higher in
women than in men and increases with age [22–24].
The differences between the age groups in women was
most pronounced in QOL where the difference was 15.2
points (76.7 vs. 61.5) and in ADL 12.7 points (81.5 vs. 68.8)
between the oldest 75–84 and the second oldest 55–74 age
group with older women reporting more complaints.
The differences between the age groups in men were
most pronounced in Sport/Rec where the difference was
12.3 points (86.5 vs. 74.2) between the age groups 35–54
and 55–74.
Similar to other population-based study cohorts, this
group of individuals randomly selected from a general popu-
lation certainly included individuals with osteoarthritis, other
musculoskeletal disorders and comorbidities influencing
their response to the HOOS questionnaire. It is known that
musculoskeletal disorders affects women more commonly
than men, and the prevalence increases with age [22].
We collected data from a wide age range and could
therefore study the hip-related self-reported complaints
across an adult population. However, although an accept-
able response rate was acquired, we cannot disregard the
fact that 33% did not answer the questionnaire, and for
whom we do not know the reasons. With missing values,
there is always the possibility that the participants who de-
clined to respond were too healthy or too sick to be inter-
ested, which would mean that the HOOS scores presented
Fig. 2 Mean HOOS scores of the subscales Pain, Symptoms, ADL,
Sports/Rec and QOL for men and women in different age groups.
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in this study could be an under- or over-estimation of the
true size of the problem.
Despite the differences in item content in subscales be-
tween the HOOS LK1.0 and 2.0, the age- and sex-specific
values in the population of this study should be applicable
to both versions of the HOOS [17]. Five questions in the
HOOS LK1.0 are not included in the HOOS LK2.0, but
the content in these removed questions is included in
other items in the HOOS LK2.0. Three items were moved
from one subscale in the HOOS LK1.0 to another subscale
in the HOOS LK2.0. The HOOS subscales scores are not
dependent on the number of items in the respective sub-
scales since the total score of each subscale is divided by
the possible maximum score for the subscale [17].
Conclusion
Hip-related pain, symptoms, function of daily life and
quality of life varied with age and sex in a population-based
sample aged 18–84 years. These findings highlight the
importance of using age- and sex-matched reference values
in studies evaluating individuals with hip complaints.
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Table 1 Age-specific HOOS scores given as mean, standard
deviation (SD), 95% confidence interval (CI) of the mean, and
median, for woman (W)) and men (M) in the different age groups
Age group 18–34 35–54 55–74 75–84
Pain
Wn 63 76 80 35
MeanSD 90.8 ± 15 86.8 ± 21.7 81.5 ± 23.9 71.8 ± 29.8
95%CL 87.1–94.5 81.9–91.7 76.3–86.7 61.9–81.6
Median 97.5 100 94.7 82.5
Mn 46 73 74 38
MeanSD 96.1 ± 9.9 88.5 ± 19.9 82.8 ± 22.6 83.5 ± 24.3
95%CL 93.2–98.9 83.9–93.1 77.7–88 75.8–91.3
Median 100 100 92.5 98.8
Symptoms
Wn 65 78 82 35
MeanSD 88.3 ± 16.3 85.6 ± 20.9 77.6 ± 24.4 67.7 ± 29.6
95%CL 84.3–92.2 80.9–90.2 72.3–82.9 57.9–77.5
Median 93.8 96.9 87.5 77
Mn 50 73 78 41
MeanSD 91 ± 14 85.8 ± 20.2 82.8 ± 23.7 80.5 ± 22.2
95%CL 87.6–95.1 81.2–90.4 77.5–88 73.8–87.3
Median 100 100 93.8 87.5
ADL
Wn 64 77 80 34
MeanSD 93.4 ± 14.6 87.7 ± 22.2 81.5 ± 24 68.9 ± 32
95%CL 89.8–97 82.8–92.7 76.3–86.6 58.1–79.6
Median 100 100 95.8 75
Mn 50 71 75 38
MeanSD 98 ± 7.4 98.7 ± 19.5 82.6 ± 24.4 80.4 ± 28.7
95%CL 95.7–99.8 85.2–94.2 77.1–88.1 71.2–89.5
Median 100 100 95.2 98.8
Sport/Rec
Wn 63 77 77 34
MeanSD 90.6 ± 19.4 83 ± 29.3 74.6 ± 32.3 55.9 ± 39.4
95%CL 85.8–95.4 76.5–89.6 76.4–81.8 42.5–69.4
Median 100 100 91.7 58.3
Mn 48 72 75 39
MeanSD 93.1 ± 20.7 86.5 ± 23 75.2 ± 33.5 69.2 ± 38.2
95%CL 87.2–98.9 81.2–91.8 62.7–82.8 57.2–81.2
Median 100 100 91.7 91.7
QOL
WN 64 77 82 34
MeanSD 89 ± 17.4 85.2 ± 23.7 76.7 ± 28.3 61.5 ± 36.9
95%CL 84.7–93.2 79.9–90.5 70.6–82.9 49.1–73.9
Median 100 100 90 67.5
Mn 48 73 76 39
Table 1 Age-specific HOOS scores given as mean, standard
deviation (SD), 95% confidence interval (CI) of the mean, and
median, for woman (W)) and men (M) in the different age groups
(Continued)
Age group 18–34 35–54 55–74 75–84
MeanSD 93 ± 13 88 ± 20 79.1 ± 27.4 81.5 ± 25.7
95%CL 89–96.5 83.4–92.6 72.9–85.2 73.5–89.6
Median 100 100 93.8 100
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